摘要 |
<p>The present invention provides compounds, and pharmaceutically acceptable compositions thereof, encompassed by any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof. The present invention also provides methods for treating an FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH by administering a therapeutically effective amount of a compound or composition comprising a compound of any of formulae (I), (II), (III), (IV), (V), or (VI), or subgenera thereof, to a patient in need thereof.</p> |
申请人 |
INFINITY PHARMACEUTICALS, INC. |
发明人 |
BEHNKE, MARK L.;CASTRO, ALFREDO C.;EVANS, CATHERINE A.;GRENIER, LOUIS;GROGAN, MICHAEL J.;LIU, TAO;SNYDER, DANIEL A.;TIBBITTS, THOMAS T. |